Arxx Therapeutics

📍 Oslo, Norway🗓 Founded 2018👥 13 employees💰 Last funded Feb 2021
Biotechnology🌐 arxxtx.com
Website LinkedIn
Founded in 2018, Arxx Therapeutics develops a first-in-class monoclonal antibody with a unique mechanism of action targeting non-resolving tissue fibrosis
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2018
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Norway
1
Frequently asked questions
Who invested in Arxx Therapeutics?
Arxx Therapeutics has 1 investors on record on gritt.io, 1 mid-stage.
When did Arxx Therapeutics last raise funding?
The most recent investment in Arxx Therapeutics recorded on gritt.io was in February 2021.
When was Arxx Therapeutics founded?
Arxx Therapeutics was founded in 2018.
What industry is Arxx Therapeutics in?
Arxx Therapeutics operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Arxx Therapeutics based?
Arxx Therapeutics is headquartered in Oslo, Norway.